| |
|
|
|
|
|
|
|||
|
Blood, 1 February 2008, Vol. 111, No. 3, pp. 1480-1488. Prepublished online as a Blood First Edition Paper on November 15, 2007; DOI 10.1182/blood-2007-09-114850.
IMMUNOBIOLOGY Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3)1 Institute and Department of Microbiology and Immunology, National Yang-Ming University; Taipei; 2 Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei; 3 National Yang-Ming University School of Medicine, Taipei; 4 Genomics Research Center, Academia Sinica, Taipei; and 5 Immunology Research Center, Taipei Veterans General Hospital, Taipei, Taiwan
Decoy receptor 3 (DcR3) is a soluble decoy receptor belonging to the tumor necrosis factor receptor (TNFR) superfamily, and its expression is not only up-regulated in cancer cells derived from various cell lineages, but also correlates with overall survival of patients with cancer. It has been shown that DcR3 sensitize cells of hematopoietic origin to TNF-related apoptosis-inducing ligand (TRAIL)–induced apoptosis; therefore, we asked whether DcR3 down-regulated host immunity by inducing immune cell apoptosis. We demonstrate that DcR3 induces dendritic cell (DC) apoptosis by activating PKC-
Related Articles in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||